September 26, 2024

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category
Go back

We are pleased to announce significant news: the first sustainable and biodegradable pregnancy test in Europe developed by Zamann Pharma Support, under the Terra Trust house brand, has been nominated for the prestigious DQS Sustainability Award 2024 in the “Sustainable Innovation” category. This nomination is a confirmation of their tireless commitment to environmental protection and sustainable innovation.

Every year, the DQS Sustainability Awards recognize companies that are pioneers in sustainability. It is one of the most important awards in the field of sustainability, recognizing companies, regardless of their size, for their innovative approaches to promoting environmental protection and social responsibility. This nomination is not only a recognition for Terra Trust, but underscores how necessary sustainable solutions have become in all areas of life, including the healthcare industry.

For Terra Trust, this nomination symbolizes much more than just a recognition of their technical innovation. It highlights the growing importance of environmental protection in a sector traditionally characterized by plastic waste and environmentally harmful disposables. Their product represents a new generation of pregnancy tests that protect the environment without compromising on quality or accuracy.

More Information in German / Original News:

Sustainability Award 2024 TerraTrustDownload

Our latest News

discover more
Christiane Herzog Foundation honors cystic fibrosis facilities at Heidelberg University Hospital

Christiane Herzog Foundation honors cystic fibrosis facilities at Heidelberg University Hospital

The Christiane Herzog Foundation has honored the Cystic Fibrosis Center at the Center for Pediatric and Adolescent Medicine and the Cystic Fibrosis Outpatient Clinic at the Thorax Clinic as the “Christiane Herzog Center.” With this award, the foundation recognizes the exceptional commitment and high level of expertise in the care of patients with cystic fibrosis […]

read more
Heidelberg neurologist and neuroscientist becomes new member of the EMBO Young Investigator Program

Heidelberg neurologist and neuroscientist becomes new member of the EMBO Young Investigator Program

Dr. Varun Venkataramani, Heidelberg Medical Faculty of Heidelberg University and German Cancer Research Center, discovered that nerve cells in the brain come into contact with tumor cells, thereby significantly promoting the growth of highly aggressive glioblastomas. In doing so, he laid the groundwork for the new field of research known as “cancer neuroscience.” The European […]

read more
VIRE: a global data platform to better understand viruses

VIRE: a global data platform to better understand viruses

Researchers release a comprehensive viral genome database covering diverse ecosystems to advance understanding of viral evolution and ecosystem functions Summary Researchers have developed VIRE, a database that integrates approximately 1.7 million viral genomes derived from more than 100,000 metagenomes worldwide. Metagenomic data is obtained by comprehensively sequencing all DNA present in an environment. This approach enables […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp